Arterial hypertension in women: Menopause as a risk window

Basil N Okeahialam1, Hadiza Agbo2, Evelyn Chuhwak1

  • 1Departments of Medicine, 291849Jos University Teaching Hospital, Jos, Nigeria.

Post Reproductive Health
|December 10, 2021
PubMed

Insights

Menopause transition worsens cardiovascular disease (CVD) risk factors in women, including higher blood pressure and adverse lipid profiles. Early screening during this period is crucial for prevention and control of CVD.

Area of Science:

  • Cardiology
  • Women's Health
  • Endocrinology

Background:

  • Cardiovascular diseases (CVD) significantly impact women's health.
  • Hypertension often clusters around menopause transition, presenting a critical window for intervention.

Purpose of the Study:

  • To investigate if the menopause transition period is associated with arterial hypertension and CVD risk factors in women.
  • To identify specific CVD risk profiles during menopause transition.

Main Methods:

  • Secondary analysis of population data on CVD risk factors in rural residents.
  • Stratification of women based on menstruation status.
  • Analysis of blood pressure, anthropometric, and biochemical variables.

Main Results:

  • Women in menopause transition showed significantly higher systolic and diastolic blood pressures, body mass index, waist and hip circumferences, and total cholesterol compared to pre-menopausal women, even after controlling for age.
  • Younger age and lower waist circumference were noted in menstruating women.

Conclusions:

  • The menopause transition is linked to a deteriorating cardiovascular disease profile in women.
  • Increased blood pressure, adverse anthropometric changes, and altered biochemical parameters during this phase contribute to CVD risk.
  • Clinicians should leverage the menopause transition for CVD risk factor screening and management to reduce morbidity and mortality.
Abstract

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
1.7K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
141
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.9K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
72